Filing metadata

Accession number
0001140361-22-021491
Form type
Form 3
Filer
Ernexa Therapeutics Inc.
CIK
CIK 748592
Filed
Jun 01, 2022
Reporting period
May 31, 2022
Description
Initial ownership

Explore SEC Filings Hub